Abstract
Immunological self-tolerance is maintained through diverse mechanisms, including deletion of autoreactive immune cells following confrontation with autoantigen in the thymus or in the periphery and active suppression by regulatory cells. A third way to prevent autoimmunity is by hiding self tissues behind a tissue barrier impermeable for circulating immune cells. The latter mechanism has been held responsible for self-tolerance within the nervous tissue. Indeed, the nervous tissues enjoy a conditionally privileged immune status: they are normally unreachable for self-reactive T and B cells, they lack lymphatic drainage, and they are deficient in local antigen-presenting cells. Yet the immune system is by no means fully ignorant of the nervous structures. An ever-growing number of brain specific autoantigens is expressed within the thymus, which ensures an early confrontation with the unfolding T cell repertoire, and there is evidence that B cells also contact CNS-like structures outside of the brain. Then pathological processes such as neurodegeneration commonly lift the brain’s immune privilege, shifting the local milieus from immune-hostile to immune-friendly. Finally, brain-reactive T cells, which abound in the healthy immune repertoire, but remain innocuous throughout life, can be activated and gain access to their target tissues. On their way, they take an ordered migration through peripheral lymphoid tissues and blood circulation, and undergo a profound reprogramming of their gene expression profile, which renders them fit to enter the nervous system and to interact with local cellule elements.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aloisi F, Ria F, Adorini L (2000) Regulation of T cell responses by CNS antigen presenting cells: different roles for microglia and astrocytes. Immunol Today 21:141–147
Anderson AC, Nicholson LB, Legge KL, Turchin V, Zaghouani H, Kuchroo VK (2000) High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: Mechanisms of selection of the self-reactive repertoire. J Exp Med 191:761–770
Antony JM, Van Marle G, Opi iW, Butterfield DA, Mallet F, Yong VW, Wallace JL, Deacon RM, Warren K, Power C (2004) Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nature Neurosci 1088–1095
Ben-Nun A, Wekerle H, Cohen IR (1981) Vaccination against autoimmune encephalomyelitis using attenuated cells of a T lymphocyte line reactive against myelin basic protein. Nature 292:60–61
Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H (1997) Experimental autoimmune encephalomyelitis: the antigen specificity of T-lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 76:355–364
Bernard CCA (1977) Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice. Clin Exp Immunol 29:100–109
Boehm T, Scheu S, Pfeffer K, Bleul CC (2003) Thymic medullary epithelial cell differentiation, thymocyte emigration, and the control of autoimmunity require lympho-epithelial cross talk via LT®R. J Exp Med 198:757–769
Brahic M, Bureau J-F (1997) Multiple sclerosis and retroviruses. Ann Neurol 42:984–985
Brocke S, Gaur A, Piercy C, Gautam AM, Gijbels K, Fathman CG, Steinman L (1993) Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 365:642–644
Brocke S, Hausmann S, Steinman L, Wucherpfennig KW (1998) Microbial peptides and superantigens in the pathogenesis of autoimmune diseases of the central nervous system. Semin Immunol 10:57–67
Campagnoni AT, Macklin WB (1988) Cellular and molecular aspects of myelin protein gene expression. Mol Neurobiol 2:41–89
Chin RK, Lo JC, Kim O, Blink SE, Christiansen PA, Peterson P, Wang Y, Ware C, Fu Y-X (2003) Lymphotoxin pathway directs thymic Aire expression. Nature Immunol 4:1121–1127
Derbinski J, Schulte A, Kyewski B, Klein L (2001) Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nature Immunol 2:1032–1039
Dittel BN, Stefanova I, Germain RN, Janeway CA (1999) Cross-antagonism of a T cell clone expressing two distinct T cells receptors. Immunity 11:289–298
Fischer H-G, Bonifas U, Reichmann G (2000) Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii. J Immunol 164:4826–4834
Flügel A, Berkowicz T, Ritter T, Labeur M, Jenne D, Li Z, Ellwart J, Willem M, Lassmann H, Wekerle H (2001) Migratory activity and functional changes of green fluorescent effector T cells before and during experimental autoimmune encephalomyelitis. Immunity 14:547–560
Freund J, Lipton MM, Thompson GE (1953) Aspermatogenesis in the guinea pig induced by testicular tissue and adjuvants. J Exp Med 97:711–725
Fujinami RS, Oldstone MBA (1985) Amino acid homology between the encephalitogenic site of myelin basic protein (MBP) and virus: mechanism for autoimmunity. Science 230:1043–1046
Furtado GC, Curotto de Lafaille MA, Kutchukhidze N, Lafaille JJ (2002) Interleukin 2 signaling is required for CD4+ regulatory T cell function. J Exp Med 196:851–857
Gaur A, Fathman CG, Steinman L, Brocke S (1993) SEB induced anergy: modulation of immune response to T cell determinants of myoglobin and myelin basic protein. J Immunol 150:3062–3069
Grima B, Zelenika D, Pessac B (1992) A novel transcript overlapping the myelin basic protein gene. J Neurochem 59:2318–2323
Heber-Katz E, Acha-Orbea H (1989) The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. Immunol Today 10:164–169
Hickey WF(2001) Basic principles of immunological surveillance of the normal central nervous system. Glia 36:118–124
Hickey WF, Hsu BL, Kimura H (1991) Tlymphocyte entry into the central nervous system. J Neurosci Res 28:254–260
Hinz T, Weidmann E, Kabelitz D (2001) Dual TCR expressing T lymphocytes in health and disease. Int.Arch Allergy Appl Immunol 125:16–20 ai]Hori S, Haury M, Coutinho A, Demengeot J (2002) Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci USA 99:8213–8218
Huitinga I, Van Rooijen N, De Groot CJA, Uitdehaag BMJ, Dijkstra CD (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172:1025–1033
Ichikawa HT, Williams LP, Segal BM (2002) Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. J Immunol 169:2781–2787
Jiang H, Zhang S-L, Pernis B (1992) Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256:1213–1215
Jiang H, Ware R, Stall A, Flaherty L, Chess L, Pernis B (1995) Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing Vß8 TCR: a role of the Qa-1 molecule. Immunity 2:185–194
Jolicoeur C, Hanahan D, Smith KM (1994) T-cell tolerance toward a transgenic β-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc Natl Acad Sci U S A 91:6707–6711
Kawakami N, Lassmann S, Li Z, Odoardi F, Ritter T, Ziemssen T, Klinkert WEF, Ellwart J, Bradl M, Krivacic K, Lassmann H, Ransohoff RM, Volk H-D, Wekerle H, Linington C, Flügel A (2004) The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J Exp Med 199:185–197
Kawakami N, Nägerl UV, Odoardi F, Bonhoeffer T, Wekerle H, Flügel A (2005) Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J Exp Med 201:1805–1814
Kerschensteiner M, Stadelmann C, Dechant G, Wekerle H, Hohlfeld R (2003) Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann Neurol 53:292–304
Klein L, Klugmann M, Nave K-A, Tuohy VK, Kyewski BA (2000) Shaping of the autoreactive T cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nature Med 6:56–61
Koh D-R, Fung-Leung W-P, Ho A, Gray D, Acha-Orbea H, Mak TW(1992) Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 256:1210–1213
Kojima K, Berger T, Lassmann H, Hinze-Selch D, Zhang Y, Gehrmann J, Wekerle H, Linington C (1994) Experimental autoimmune panencephalitis and uveoretinitis in the Lewis rat transferred by T lymphocytes specific for the S100ß molecule, a calcium binding protein of astroglia. J Exp Med 180:817–829
Kojima K, Lassmann H, Wekerle H, Linington C (1997) The thymus and self tolerance: co-existence of encephalitogenic S-100ß specific T cells and their nominal autoantigen, S-100ß, in the normal rat thymus. Int Immunol 9:897–904
Lang HLE, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart DI, Bell JI, Jones EY, Fugger L (2002) A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nature Immunol 3:940–943
Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233–240
Lanzavecchia A, Sallusto F (2001) Regulation of T cell immunity by dendritic cells. Cell 106:263–266 ai]Lassmann H, Brück W, Lucchinetti C (2001) Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 7:115–121
Lider O, Reshef T, Béraud E, Ben-Nun A, Cohen IR (1988) Anti-idiotypic network induced by T-cell vaccination against experimental autoimmune encephalomyelitis. Science 239:181–183
Linington C, Webb M, Woodhams PL (1984) A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J Neuroimmunol 6:387–396
Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130:443–454
Linington C, Morgan BP, Scolding NJ, Wilkins P, Piddlesden S, Compston DA (1989) The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112:895–911
Litzenburger T, Fässler R, Bauer J, Lassmann H, Linington C, Wekerle H, Iglesias A (1998) Blymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med 188:169–180
Litzenburger T, Blüthmann H, Morales P, Pham-Dinh D, Dautigny A, Wekerle H, Iglesias A (2000) Development of MOG autoreactive transgenic B lymphocytes: Receptor editing in vivo following encounter of a self-antigen distinct from MOG. J Immunol 165:5360–5366
Llewelyn M, Cohen J (2003) Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis 2:156–162
Marrack P, Kappler JW (1990) The staphylococcal enterotoxins and their relatives. Science 248:705–710
Martiney JA, Rajan AJ, Charles PC, Cerami A, Ulrich PC, Macphail S, Tracey KJ, Brosnan CF (1998) Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage deactivating agent. J Immunol 160:5588–5595
Mathis D, Benoist C (2004) Back to central tolerance. Immunity 20:509–516
Mead RJ, Singhrao SK, Neal JW, Lassmann H, Morgan BP (2002) The membrane attack complex demyelination associated with a of complement causes severe cute axonal injury. J Immunol 168:458–465
Melms A, Schalke BCG, Kirchner T, Müller-Hermelink HK, Albert E, Wekerle H(1988) Thymus in myasthenia gravis: isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest 81:902–908
Nemazee D, Hogquist KA (2003) Antigen receptor selection by editing or downregulation of V(D)J recombination. Curr Opin Immunol 15:182–189
Nussenzweig MC (1998) Immune receptor editing: revise and select. Cell 95:875–878
Olivares-Villagómez D, Wang Y, Lafaille JJ (1998) Regulatory CD4+ T cells expressing endogenous T cell receptor chains protectmyelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med 188:1883–1894
Pender MP, Nguyen KB, McCombe PA, Kerr JFR (1991) Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 104:81–87
Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet J, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, Mandr B, The Collaborative Research Group on Multiple Sclerosis (1997) Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci U S A 94:7583–7588
Piddlesden SJ, Storch MK, Hibbs M, Freeman AM, Lassmann H, Morgan BP (1994) Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J Immunol 152:5477–5484
Posnett DN Yarilina AA (2001) Sleeping with the enemy—endogenous superantigens in humans. Immunity 15:503–506
Pribyl TM, Campagnoni CW, Kampf K, Kashima T, Handley VW, McMahon J, Campagnoni AT (1993) The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous system. Proc Natl Acad Sci U S A 90:10695–10699
Rott O, Wekerle H, Fleischer B (1992) Protection from experimental allergic encephalomyelitis by application of a bacterial superantigen. Int Immunol 4:347–354
Sarantopoulos S, Lu LR, Cantor H (2004) Qa-1 restriction of CD8+ suppressor T cells. J Clin Invest 114:1218–1221
Schiffenbauer J, Johnson HM, Butfiloski EJ, Wegrzyn L, Soos JM (1993) Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A 90:8543–8546
Schlissel MS (2003) Regulating antigen-receptor gene assembly. Nature Rev Immunol 3:890–899
Schluesener HJ, Sobel RA, Linington C, Weiner HL (1987) A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol 139:4016–4021
Schmied M, Breitschopf H, Gold R, Zischler H, Rothe G, Wekerle H, Lassmann H (1993) Apoptosis of T lymphocytes-a mechanism to control inflammation in the brain. Am J Pathol 143:446–452
Schwartz M (2001) Protective autoimmunity as a T-cell response to central nervous system trauma: prospects for therapeutic vaccines. Progr Neurobiol 65:489–496
Segal BM, Shevach EM (1996) IL-12 unmasks latent autoimmune disease in resistant mice. J Exp Med 184:771–775
Serafini B, Columba-Cabezas S, Di Rosa F, Aloisi F (2000) Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am J Pathol 157:1991–2002
Steinman L (1996) A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc Natl Acad Sci U S A 93:2253–2256
Su I Tarakhovsky A (2000) B-1 cells: orthodox or conformist? Curr Opin Immunol 12:191–194
Sun D, Qin Y, Chluba J, Epplen JT, Wekerle H (1988) Suppression of experimentally induced autoimmune encephalomyelitis by cytolyticT-T-cell interactions. Nature 332:843–845
Suter T, Malipiero U, Otten L, Ludewig B, Muelethaler-Mottet A, Mach B, Reith W, Fontana A (2000) Dendritic cells and differential use of MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis. Eur J Immunol 30:794–802
Swierkosz JE, Swanborg RH (1977) Immunoregulation of experimental allergic encephalomyelitis: conditions for induction of suppressor cells and analysis of mechanism. J Immunol 119:1501–1506
Tran EH, Hoekstra K, Van Rooijen N, Dijkstra CD, Owens T (1998) Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage depleted mice. J Immunol 161:3767–3775
Uchida D, Hatakeyama S, Matsushima A, Han HW, Ishido S, Hotta H, Kudoh J, Shimizu N, Doucas V, Kuroda N, Matsumoto M (2004) AIRE functions as an E3 ubiquitin ligase. J Exp Med 199:167–172
Vajkoczy P, Laschinger M, Engelhardt B (2001) α4-Integrin-VCAM binding mediates G protein independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J Clin Invest 108:557–565
Van de Keere F, Tonegawa S (1998) CD4+ T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. J Exp Med 188:1875–1882
Vanderlugt CL, Miller SD (2002) Epitope spreading in immune mediated diseases: implications for immunotherapy. Nature Rev Immunol 2:85–95
Waldner H, Collins M, Kuchroo VK (2004) Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J Clin Invest 113:990–997
Walker LSK, Abbas AK (2002) The enemy within: keeping self-reactive T cells at bay in the periphery. Nature Rev Immunol 2:11–19
Wekerle H, Ketelsen U-P (1977) Intrathymic pathogenesis and dual genetic control of myasthenia gravis. Lancet i:678–680
Wekerle H, Linington C, Lassmann H, Meyermann R (1986) Cellular immune reactivity within the CNS. Trends Neurosci 9:271–277
Wucherpfennig KW, Strominger JL (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695–705
Zuklys S, Balciunaite G, Agarwal A, Fasler-Kan E, Palmer E, Holländer GA (2000) Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Immunol 165:1976–1983
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wekerle, H. (2006). Breaking Ignorance: The Case of the Brain. In: Radbruch, A., Lipsky, P.E. (eds) Current Concepts in Autoimmunity and Chronic Inflammation. Current Topics in Microbiology and Immunology, vol 305. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-29714-6_2
Download citation
DOI: https://doi.org/10.1007/3-540-29714-6_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-29713-0
Online ISBN: 978-3-540-29714-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)